Cargando…
Evaluation of a Radiolabeled Macrocyclic Peptide as Potential PET Imaging Probe for PD−L1
The interaction between the immune checkpoint PD‐1 and PD−L1 promotes T‐cell deactivation and cancer proliferation. Therefore, immune checkpoint inhibition therapy, which relies on prior assessment of the target, has been widely used for many cancers. As a non‐invasive molecular imaging tool, radiot...
Autores principales: | Jouini, Nedra, Cardinale, Jens, Mindt, Thomas L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320808/ https://www.ncbi.nlm.nih.gov/pubmed/35388635 http://dx.doi.org/10.1002/cmdc.202200091 |
Ejemplares similares
-
Preclinical Evaluation of Radiolabeled Peptides for PET Imaging of Glioblastoma Multiforme
por: Novy, Zbynek, et al.
Publicado: (2019) -
Evaluation of (68)Ga-Radiolabeled Peptides for HER2 PET Imaging
por: Ducharme, Maxwell, et al.
Publicado: (2022) -
Triazine-Based Tool Box for Developing Peptidic PET
Imaging Probes: Syntheses, Microfluidic Radiolabeling, and Structure–Activity
Evaluation
por: Li, Hairong, et al.
Publicado: (2014) -
Manganese in PET imaging: Opportunities and challenges
por: Brandt, Marie, et al.
Publicado: (2019) -
Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe
por: Honarvar, Hadis, et al.
Publicado: (2018)